![Sample our Food Science & Technology journals, sign in here to start your access, latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5936/TOC-Subject-Sample-2021-Food-Science-Technology.jpg"})
Abstract
Aim: The definition of metabolic syndrome (MetSy) in patients with coronary heart disease (CHD) remains problematic because of concomitant treatment. We speculate, which definition is suitable in terms of long-term glycemic status. Methods: We analyzed 979 patients with stable CHD. Four different MetSy definitions were used: ‘standard Adult Treatment Panel III (ATP)’, ‘modified ATP’ (not using antihypertensive treatment as an alternative criterion), ‘atherogenic dyslipidemia’ or ‘hypertriglyceridemic waist’. Results: The presence of ‘hypertriglyceridemic waist’ was associated with almost twofold higher risk (OR 1.79; 95% CI: 1.19 – 2.68) of hemoglobin A1c ≥48. Predictive power of standard or modified ATP definitions diminished after adjustment. Conclusion: In CHD patients, the simplified MetSy definition using ‘hypertriglyceridemic waist’ provides better prediction for glycemic control than ATP definition.